Follow
Alok Kumar
Alok Kumar
Ph.D. (Medicine), PI: Prof. Tasuku Honjo (Nobel Prize, Medicine, 2018), Kyoto University, Kyoto
Verified email at pitt.edu - Homepage
Title
Cited by
Cited by
Year
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
Kenji Chamotoa,1, Partha S. Chowdhurya,1, Alok Kumara, Kazuhiro Sonomurab,c ...
PNAS, 2017
358*2017
PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy
PS Chowdhury, K Chamoto, A Kumar, T Honjo
Cancer immunology research 6 (11), 1375-1387, 2018
2522018
Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
A Kumar, K Chamoto, PS Chowdhury, T Honjo
Elife 9, e52330, 2020
492020
Immune metabolism in PD-1 blockade-based cancer immunotherapy
A Kumar, K Chamoto
International immunology 33 (1), 17-26, 2021
332021
A combination of linalool, vitamin C, and copper synergistically triggers reactive oxygen species and DNA damage and inhibits Salmonella enterica subsp. enterica Serovar Typhi …
T Ghosh, SK Srivastava, A Gaurav, A Kumar, P Kumar, AS Yadav, ...
Applied and Environmental Microbiology 85 (4), e02487-18, 2019
332019
Targeted suppression of metastasis regulatory transcription factor SOX2 in various cancer cell lines using a sequence-specific designer pyrrole–imidazole polyamide
M Malinee, A Kumar, T Hidaka, M Horie, K Hasegawa, GN Pandian, ...
Bioorganic & Medicinal Chemistry 28 (3), 115248, 2020
232020
Aptamer technology for the detection of foodborne pathogens and toxins
A Kumar, M Malinee, A Dhiman, A Kumar, TK Sharma
Advanced biosensors for health care applications, 45-69, 2019
182019
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors
K Lontos, Y Wang, SK Joshi, AT Frisch, MLJ Watson, A Kumar, AV Menk, ...
Journal for Immunotherapy of Cancer 11 (3), 2023
142023
Aptamer-mediated Nanobiosensing for health monitoring
M Malinee, A Kumar, A Dhiman, TK Sharma
Advanced Biosensors for Health Care Applications, 227-248, 2019
12*2019
Nanomedicine: diagnosis, treatment, and potential prospects
M Bansal, A Kumar, M Malinee, TK Sharma
Nanoscience in Medicine Vol. 1, 297-331, 2020
112020
Mitochondrial Manipulation Improves Anti-Tumor Immunity
MM Alok Kumar
Acta Scientific Cancer Biology 3 (12), 28-30, 2019
32019
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
K Lontos, Y Wang, M Colbert, A Kumar, S Joshi, M Philbin, Y Wang, ...
OncoImmunology 11 (1), 2131229, 2022
12022
Trending approaches in electrospinning and electrospraying for biomedical applications
P Dubey, I Matai, D Garg, A Kumar, V Takiar
Biomedical Applications of Electrospinning and Electrospraying, 333-354, 2021
12021
Redox and detox: Malate shuttle metabolism keeps exhausted T cells fit
A Kumar, GM Delgoffe
Cell Metabolism 35 (12), 2101-2103, 2023
2023
Role of Nanoparticles in Cancer Immunotherapy
M Malinee, A Kumar
Bionanotechnology in Cancer, 495-526, 2022
2022
Tumors attenuating the mitochondrial activity in T cells escape from PD-1 blockade therapy
K Alok
Kyoto University, 2020
2020
Blocking energy production in immune cells helps tumours escape treatment
A Kumar
https://medicalxpress.com/news/2020-03-blocking-energy-production-immune …, 2020
2020
Inhibiting energy production in immune T-cells allows some tumors to escape treatment
A Kumar
https://www.news-medical.net/news/20200303/Inhibiting-energy-production-in …, 2020
2020
Blocking energy production in immune cells helps tumours escape treatment
A Kumar
https://www.eurekalert.org/pub_releases/2020-03/e-bep030320.php, 2020
2020
T cell mitochondria dysregulation by tumor-derived immunosuppressive factors induces unresponsiveness to the PD-1 blockade cancer immunotherapy.
A Kumar
Newsletter, 2019 [RI Center, Kyoto University] 63, p: 4-7, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20